Needham analyst David Saxon downgrades Globus Medical (NYSE:GMED) from Buy to Hold.
Fifth Third Bancorp Q1 Bottomline Beats Expectations; Net Interest Income Surges 27%
Fifth Third Bancorp (NASDAQ:FITB) reported interest income of $2.22 billion in the first quarter, up 72% year over year, missing…